Bed Stay – Immobility and Occurrence of Deep Vein Thrombosis (DVT)
The risk for DVT in active adults is .001%. Every step taken activates calf muscle contractions, promotes venous outflow towards the heart, and prevents DVT.
Once hospitalized, immobility sets in and the rate for DVT increases 3,000 times to 3% or higher.
Extended bed stay leads to calf muscle pump failure and a significant reduction in venous outflow, which increases the risk for clotting and DVT. Alarmingly, 8-10% of hospital deaths are attributed to DVT.
Bed stay increases risk for DVT.
Patients undergoing surgery are assessed for inherent risk factors for developing DVT. The Caprini Risk Assessment Scoring Model is the gold standard in identifying factors that increase a patient’s risk for developing DVT. The Caprini DVT Risk Assessment identifies 4% of hospital admissions as very high-risk for developing DVT and the probability of developing DVT at a rate of 6.5% – 18%. SCDs are not provided for use during home recovery which exposes high-risk patients and hospitals to unwanted readmissions due to DVT.
The Legacy® System supports hospitals with an At-Home Prevention Program that provides maximum protection to very high-risk patients during hospital stay and throughout home recovery. Why expose hospitals to unwanted readmissions costing over $19,000 with treatments and a LOS of 5 days.
Score
0-2
3-5
5-8
9+
Risk
Low
Moderate
High-Risk
Very High-Risk
% of Patients
4%
84%
8%
4%
DVT Rate
1.5%
3%
6%
6.5-18%
Recommended IPC Therapy
Optional
Admission to Discharge
Admission and At-Home
Admission and At-Home
Using a DVT rate of 10% from the above data, hospitals with 10,000 admissions are exposed to incurring unwanted readmissions costing $794,600. Legacy’s At-Home DVT Prevention Program is projected to reduce DVT 70%, which reduces readmissions and helps hospitals save approximately $556,220. Less the cost for the Legacy IPC System ($41,150) helps generate net savings of $515,070.
Note: This does not include the savings realized with early discharges.
For high-risk and very high-risk patients, the need for a continued At-Home DVT Prevention Therapy is elevated until those patients return to an active lifestyle.
Hospitals have been using bed-mounted sequential compression devices (SCD) for over 40 years to help prevent DVT. The technology has changed little other than going from weighing 12 pounds to now 6-8 pounds. SCDs still do not promote ambulation. Patient compliance with SCDs is < 45%. Due to bulky size and high cost to replace damaged SCDs, hospitals do not provide these devices to high-risk patients during home recovery, which leads to delayed discharges, unwanted DVTs, and costly readmissions.
Nurses and Patients are frustrated with SCDs for the following reasons:
High Importance: Fail to promote ambulation. Hassle to remove and reapply SCD sleeves every time patient leaves the bed. Patient discomfort with heat buildup due to non-breathable limb sleeves. Constant pump noise disturbs rest and sleep, leading to poor patient compliance. Tissue pressure injuries developing due to SCD tubing rubbing against the skin is a significant issue with patients and nurses.
Moderate Importance: Inconsistent pump reliability, the difficulty with attaching hoses, sleeves, and power cords, and issues of tripping are concerns for nurses.
Fact: SCDs are financially costing hospitals millions each year!
- SCDs do not promote ambulation which increases the risk for hospital acquired (HA) complications including DVT, pneumonia, and tissue pressure injuries.
HA-complications penalize hospitals with longer length of stay (LOS) and added unreimbursed treatments costing millions. - Discharge planners are reluctant to discharge high-risk or very high-risk patients early since hospital policy does not provide SCDs for use during home recovery, even though 50% of DVTs develop after being discharged. A one-day delay in discharging a patient costs hospitals upwards of $2,000.
- SCDs do not support an At-Home DVT Prevention Program. Every unwanted readmission due to DVT costs hospitals as much as $19,782.
- CMS’s Never Event Policy penalizes hospitals financially when self-reporting hospital data shows rate of DVT is above the baseline. Combining low patient compliance (<50%) and a failure to provide an At-Home DVT Program increases the DVT rates and further exposes hospitals to Medicare’s Never Event penalties.
- Nurses are frustrated with the amount of unproductive time spent removing and reapplying SCD limb sleeves with every bed transfer. Nurses report spending at least 5-minutes every time a patient has the need to visit the bathroom, sit in a chair, or a required treatment. Over a 3-day LOS, this wasted time is indirectly costing hospitals an additional $75.00.
Fact: Those inexpensive SCD limb sleeves are failing hospitals, nurses, and patients in reducing DVT and are costing hospitals millions each year.
Are YOU open to a new, transformational device that improves patient compliance 85%, reduces DVT 70%, and saves hospitals $$$$$?
Legacy® IPC is more than a portable DVT device. It’s a system designed to prevent HA-DVT, Pneumonia, and Tissue Pressure Injuries.
Legacy® IPC meets the clinical, functional, and financial needs for today’s modern hospitals.
Legacy® IPC Device – Promotes Ambulation
- Weighs 68 grams
- Promotes patient compliance 85%
- Reduces DVT 70%
- Delivers 45 mmHg every minute for 15 seconds
- Operates in total silence
- Improves nurse productivity10%
- Promotes early discharges
- Supports an at-home DVT prevention program
- Helps prevent HA-complications
- Reusable with a one-year warranty
- Proven to significantly reduce cost
The Legacy® System represents transformational technology in preventing DVT beginning on day one and until patients are fully ambulatory.
Legacy®Comfort Sleeves
- One-size-fits-all
- Lightweight – 74 grams
- Soft, breathable fabric
- Conforming fabric
- Prevents slippage
- Comfortable to wear for extended hours
Legacy® IPC
- Travels with patients
- Prevents HA- complications
- No sleeves to remove/reapply
- No hoses or cords
- Supports at-home DVT program
Legacy® Monitoring APP and Locking Station
- Bluetooth/W-Fi
- Data retrieval
- Patient compliance
- Steps, cadence, and overall patient activity
- Device performance
- Geolocation
Legacy® Charging Hub Station
- Charges 20 units at a time
- Fully charged in 3 hours
- Organized charging system
- Reduces room clutter from plug-ins
The Legacy® IPC is designed to improve the level of care, patient compliance, nurse efficiency, the rate of early discharges, reduce hospital acquired complications (DVT, pneumonia, and tissue pressure injuries), and save hospitals having 1,000 annual discharges approximately $136,000 per year.
1. Legacy® IPC promotes ambulation which helps improve deep breathing, the clearing of mucus, and reduces the risk for developing HA-pneumonia.
Increasing wear time along with frequent periods of ambulation during the day reduces interface pressure, improves overall circulation, and reduces the risk for tissue pressure injuries.
Legacy reduces HA-complications and the exposure to added treatments and costs.
2. The main measure of efficacy for IPC is the flow rate over a given time which indicates the Total Volume Flow of venous blood expelled.
Legacy’s transformational pump weighs 5 grams, delivers inflation every minute for 15 seconds at 45 mmHg, and mobilizes venous volume flow equal to bulky SCDs weighing 8 pounds.
Decreasing DVT 70% helps reduce hospitals’ exposure to unwanted readmissions and potential costly legal issues.
3. Patients find noisy SCDs irritating, impacts quality rest/sleep, leading to low compliance and higher rates of DVT.
Legacy’s patented pump runs below 57 dbA, an inaudible level, making it the only device to operate in total silence.
Improved rest and sleep helps accelerate recovery leading to early discharge which saves hospitals significant dollars.
4. The vinyl sleeve fabric for SCDs is non-breathable.
Legacy® Comfort Sleeves are lightweight, soft, breathable fabric designed to promote ambulation, wear time, and patient compliance (85%).
Improving ambulation and wear time is proven to reduce DVT and unwanted readmissions which saves hospitals significant dollars.
5. SSCD sleeves are available in S/M/L. Nurses are frustrated with having to remove and reapply the limb sleeves every time a patient needs to transfer from the bed.
The one-size-fits-all Legacy® Comfort Sleeves reduce inventory issues. Nurses appreciate not having to remove and reapply the Comfort Sleeves.
Legacy® Comfort Sleeves improve efficiencies which saves hospitals significant dollars.
6-A. The Legacy® Monitoring APP with Bluetooth/Wi-Fi allows nurses to monitor device performance in real time during hospital stay and while recovering at home.
Traffic Light System
• On – Green
• Blockage – Red
• Low Battery – Amber
Improved monitoring/tracking enhance device performance, assures positive outcomes, and helps hospitals reduce costs.
6-B. The Legacy® Monitoring APP monitors and tracks patient compliance in real time during hospital stay and while recovering at home.
Monitoring and tracking the following patient metrics: patient compliance, steps, cadence, and overall patient activity helps discharge planners make informed decisions leading to early discharges and helps hospitals save as much as $2,500.
The Legacy® APP also provides Geolocation which tracks device location (Hospital, Patient’s Home, In-transit), and during reprocessing in Central Supply.
In addition, the Legacy® APP monitors and provides status regarding Pump Lifetime Data.
Promoting high patient compliance helps reduce DVT and early discharges generates savings of $2,000 or more per discharge.
7. Legacy® IPC device and bladder system are reusable, which helps hospitals realize significant savings. The Legacy device has a one-year warranty. The Legacy®device is proven to operate for two years.
The single patient Legacy® Comfort Sleeves are purchased as a replacement item.
Legacy® IPC saves hospitals at least $130 per patient versus SCDs when considering better compliance 85% and reduced DVT by 70%. Providing the Legacy® IPC to high-risk patients during hospital stay and at-home delivers continuity of care and lowers costs.
The Legacy Monitoring APP Program monitors patient compliance and device performance. The Legacy® APP enhances nurse communications with patients, promotes compliance, generates positive outcomes, and keeps the daily cost for the At-Home DVT Program under $2.00 for high-risk patients being discharged after wearing the Legacy® IPC for 4-days.
Why continue using SCDs that fail to …
- Promote high patient compliance.
- Reduce noise causing sleep disturbance and discomfort.
- Promote ambulation which leads to higher DVT rates.
- Reduce the risk of HA-DVT, pneumonia, and tissue pressure injuries.
- Generate early discharges that further penalize hospitals financially.
- Support an At-Home DVT Prevention Program leading to unwanted readmissions.
- Improve nurse productivity due to excessive time spent with SCD sleeves.
CALL US